학술논문
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
Document Type
Article
Author
Source
In Immuno-Oncology and Technology September 2022 15
Subject
Language
ISSN
2590-0188